12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

MuGard regulatory update

Access Pharmaceuticals said China's State Food and Drug Administration (SFDA) approved a regulatory application from partner Rhei Pharmaceuticals Inc. (Hong Kong, China) for MuGard mucoadhesive oral rinse to treat oral mucositis...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >